{"schema_version":"secwatch.filing_event.v1","accession":"0001178670-25-000062","form_type":"8-K","ticker":"ALNY","cik":"0001178670","company_name":"ALNYLAM PHARMACEUTICALS, INC.","filed_at":"2025-05-13T23:59:59+00:00","discovered_at":"2026-05-14T18:02:47.713426+00:00","generated_at":"2026-05-21T13:08:46.863884+00:00","sec_items":["5.03","5.07","9.01"],"event_type":"other","sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.25,"confidence":"high","headline":"Alnylam shareholders approve officer exculpation charter amendment, re-elect four directors","bullets":["Filed certificate of amendment to allow officer exculpation; approved with 111.5M for, 7.1M against.","Re-elected four Class III directors (Carolyn Bertozzi, Margaret Hamburg, Colleen Reitan, Amy Schulman) with majority support.","Approved Second Amended and Restated 2018 Stock Incentive Plan (114.0M for, 4.6M against).","Non-binding advisory vote on executive compensation passed (111.7M for, 6.9M against).","Ratified PwC as independent auditors for FY2025 (117.0M for, 6.4M against)."],"urls":{"canonical":"https://secwatch.observer/filing/0001178670-25-000062","json":"https://secwatch.observer/filing/0001178670-25-000062.json","markdown":"https://secwatch.observer/filing/0001178670-25-000062.md","text":"https://secwatch.observer/filing/0001178670-25-000062.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1178670/000117867025000062/0001178670-25-000062-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1178670/000117867025000062/alny-20250508.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-21T13:08:46.863884+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"74ef3abe9b0b19f1266b8c44a34b9a5c68b17275","claim":"ALNYLAM PHARMACEUTICALS, INC.: Certificate of Amendment filed to allow for officer exculpation (effective 2025-05-08).","evidence_excerpt":"the Company filed a Certificate of Amendment to the Company’s Restated Certificate of Incorporation to allow for officer exculpation (the “Certificate of Amendment”).","evidence_source":"SEC 8-K Item 5.03/5.05/5.06","evidence_url":"https://www.sec.gov/Archives/edgar/data/1178670/000117867025000062/0001178670-25-000062-index.htm","confidence":0.9,"family_label":"Governance Changes","details":[{"label":"Change","value":"charter amendment"},{"label":"Effective","value":"2025-05-08"}],"fact_type":"governance_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}